Skip to content
Biotron Limited
  • Home
  • About Us
    • Board of Directors
    • Management Team
  • Technology
    • Clinical programs
    • Non-clinical programs
    • Intellectual property
  • News/Resources
    • Newsletters
    • In the news
    • Scientific Presentations
    • Scientific Publications
  • Investor Centre
    • ASX Announcements
    • Financial Reports
      • Annual
      • Half-year
      • Quarterly
    • Corporate Directory
    • Shareholder services
    • Rights Issue
    • Top 40 Shareholders
    • Top 40 Option Holders
    • Corporate Governance
    • Corporate Presentations
  • Contacts

2020

Half-year Report 31 December 2019

27 February 2020 by Audrey Thomson

Half-year Report 31 December 2019

Categories 2020, ASX Announcements, Half-year reports

Shareholder Update

25 February 2020 by Audrey Thomson

Shareholder Update

Categories 2020, ASX Announcements

Biotron to Test its Compounds Against Coronavirus

6 February 2020 by Audrey Thomson

Biotron to Test its Compounds Against Coronavirus

Categories 2020, ASX Announcements

Appendix 3B – New Issue Announcement

31 January 2020 by Audrey Thomson

Appendix 3B – New Issue Announcement

Categories 2020, ASX Announcements

Quarterly Report 31 December 2019

24 January 2020 by Audrey Thomson

Quarterly Report 31 December 2019

Categories 2020, ASX Announcements, Quarterly Reports

Biotron Response to ASX Price Query

23 January 2020 by Audrey Thomson

Biotron Response to ASX Price Query

Categories 2020, ASX Announcements

Appendix 3Y – Change of Director’s Interest Notice

22 January 2020 by Audrey Thomson

Appendix 3Y – Change of Director’s Interest Notice

Categories 2020, ASX Announcements
Newer posts
← Previous Page1 Page2 Page3
© Biotron Limited 2016       ABN 60 086 399 144        Site updated 12 December 2025        Legal Notices and Privacy
Cleantalk Pixel